Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
McKinsey
Colorcon
US Army
QuintilesIMS
Dow
Cantor Fitzgerald
Mallinckrodt

Generated: December 12, 2018

DrugPatentWatch Database Preview

OCREVUS Drug Profile

« Back to Dashboard

Summary for Tradename: OCREVUS
Patents:39
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for OCREVUS

US Patents for OCREVUS

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28 ➤ Sign Up Genentech, Inc. (South San Francisco, CA) ➤ Sign Up RX search
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28 ➤ Sign Up ASSISTANCE PUBLIQUE--HOPITAUX DE PARIS (Paris, FR) UNIVERSITE PARIS DIDEROT (PARIS VII) (Paris, FR) UNIVERSITE DE NICE--SOPHIA ANTIPOLIS (Nice, FR) INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (Paris, FR) ➤ Sign Up RX search
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28 ➤ Sign Up BEUTSCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN (DRFZ) (Berlin, DE) ➤ Sign Up RX search
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28 ➤ Sign Up Alexion Pharmaceuticals, Inc. (New Haven, CT) ➤ Sign Up RX search
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28 ➤ Sign Up University of Maryland, Baltimore (Baltimore, MA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Cantor Fitzgerald
Chinese Patent Office
Daiichi Sankyo
Fuji
Accenture
Mallinckrodt
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.